RESPIRATORY DISEASES
McMaster University
Hamilton, CanadáPublications in collaboration with researchers from McMaster University (2)
2020
-
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 5, pp. 453-460
2018
-
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437